| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 10/04/2011 | CA2507501C 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 10/04/2011 | CA2452871C Oxymorphone controlled release formulations |
| 10/03/2011 | WO2011027806A1 Therapeutic agent for anxiety disorders |
| 10/03/2011 | CA2772922A1 Therapeutic agent for anxiety disorders |
| 10/03/2011 | CA2772920A1 Therapeutic agent for mood disorders |
| 09/29/2011 | WO2011117211A1 Substituted pyridazines having herbicidal action |
| 09/29/2011 | WO2011117195A1 Substituted pyridines having herbicidal action |
| 09/29/2011 | WO2011087712A3 Tricyclic derivatives and their pharmaceutical use and compositions |
| 09/29/2011 | US20110237794 Spiro Compounds And Methods Of Use |
| 09/29/2011 | US20110236310 Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method |
| 09/29/2011 | CA2794153A1 Chemical compounds |
| 09/28/2011 | EP2368551A2 Methods of use for cyclopamine analogs |
| 09/28/2011 | EP2367830A1 1-oxa-8-azaspiro [4, 5] decane- 8 -carboxamide compounds as faah inhibitors |
| 09/28/2011 | EP2367826A1 Modulators of amyloid beta. |
| 09/28/2011 | EP2367821A1 C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof |
| 09/28/2011 | EP1881827B1 Fused thiazole derivatives as kinase inhibitors |
| 09/28/2011 | CN102203060A 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists |
| 09/28/2011 | CN102199156A Preparation of gelsemine from gelsemium extract by using chromatography |
| 09/28/2011 | CN102199155A Method for preparing humantenmine from elegant Jessamine extracts |
| 09/28/2011 | CN102199154A Novel synthesis method for pyrrole derivatives |
| 09/28/2011 | CN101723950B Method for extracting coptisine |
| 09/27/2011 | US8026249 Deuterium-enriched topotecan |
| 09/27/2011 | US8026246 Aurora kinase inhibitors for inhibiting mitotic progression |
| 09/27/2011 | US8026239 Cell differentiation inducer |
| 09/27/2011 | CA2503646C Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 09/27/2011 | CA2418109C Polymorphs of an epothilone analog |
| 09/22/2011 | WO2011116282A2 Nicotinic acetylcholine receptor agonists |
| 09/22/2011 | WO2011114275A1 Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
| 09/22/2011 | WO2011113802A2 Imidazopyridine compounds, compositions and methods of use |
| 09/22/2011 | WO2011100502A8 7-aminofuropyridine derivatives |
| 09/22/2011 | WO2011080510A8 Tricyclic compounds for use as kinase inhibitors |
| 09/22/2011 | WO2009111653A3 Antiviral therapeutic agents |
| 09/22/2011 | WO2009037111A3 Method for the production of 1,3-dioxolane-2-ones and carboxylic acid esters by means of transacylation in basic reaction conditions |
| 09/22/2011 | US20110230516 CCR1 Antagonists and Methods of Use Therefor |
| 09/22/2011 | US20110230515 Compounds and methods for treatment and prevention of diseases |
| 09/22/2011 | US20110230493 1-OXA-8-Azaspiro [4,5] Decabe-8-Carboxamide Compounds as FAAH Inhibitors |
| 09/22/2011 | US20110230346 Biphenyl-Substituted Cyclic Ketoenols |
| 09/22/2011 | CA2793024A1 Imidazopyridine compounds, compositions and methods of use |
| 09/22/2011 | CA2791737A1 Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
| 09/21/2011 | EP2260042B1 Substituted spirocyclic cyclohexane derivatives |
| 09/21/2011 | EP1505963B9 Hepatitis c virus inhibitors |
| 09/21/2011 | EP1436298B1 Himbacine analogues as thrombin receptor antagonists |
| 09/21/2011 | CN102190661A Tricyclic benzopyran compound as anti-arrhythmic agents |
| 09/21/2011 | CN102190658A Structural analogue of antineoplastic marine natural product ecteinascidins |
| 09/21/2011 | CN102190621A N-heterocyclyl-phenylsubstituierte cyclische ketoenole |
| 09/21/2011 | CN101589046B Azaspiro derivatives |
| 09/20/2011 | US8022207 Compound having affinity to amyloid |
| 09/20/2011 | US8022102 Unsaturated tetracyclic tetrahydrofuran derivatives |
| 09/20/2011 | US8022085 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 09/20/2011 | US8022078 Pyrimidine classical cannabinoid compounds and related methods of use |
| 09/20/2011 | US8022060 Spirocyclic heterocyclic derivatives and methods of their use |
| 09/20/2011 | CA2617957C Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 09/20/2011 | CA2467774C Solubilized topoisomerase poisons |
| 09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 09/15/2011 | WO2011041989A3 Tricyclic and tetracyclic systems with activity on the central-nervous and vascular systems |
| 09/15/2011 | US20110224078 Substituted Pyridines Having a Herbicidal Effect |
| 09/14/2011 | EP2364976A1 S1P receptor modulating compounds and use thereof |
| 09/14/2011 | EP2364705A2 Modulators of muscarinic receptors |
| 09/14/2011 | EP2364295A1 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists |
| 09/14/2011 | EP2041140B1 Aziridinyl-epothilone compounds |
| 09/14/2011 | EP1896421B1 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 09/14/2011 | EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof |
| 09/14/2011 | EP1346982B1 Vla-4 inhibitors |
| 09/14/2011 | CN1918172B Rifamycin analogs and uses thereof |
| 09/14/2011 | CN1436191B Antitumoral ecteinascidin derivatives |
| 09/14/2011 | CN102186849A Phenanthroindolizidine compound and nf?b inhibitor containing same as active ingredient |
| 09/14/2011 | CN102186845A S1p receptors modulators and their use thereof |
| 09/14/2011 | CN102180886A Asymmetric catalytic synthesis method for Galanthamine |
| 09/14/2011 | CN102180885A Sanguinarine alcoholate and chelerythrine alcoholate and preparation method and application thereof in animal acaricidal drugs |
| 09/14/2011 | CN101768164B Naloxone hydrochloride compound with high purity |
| 09/14/2011 | CN101448837B Novel epoxy compound and method for producing the same |
| 09/14/2011 | CN101397302B 9-substituted homocamptothecins compounds and its use as medicaments |
| 09/13/2011 | US8017643 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/13/2011 | US8017641 P38 inhibitors and methods of use thereof |
| 09/13/2011 | US8017619 Compositions useful as inhibitors of protein kinases |
| 09/13/2011 | US8017604 Imidazopyridines |
| 09/13/2011 | CA2560402C Tetrahydroquinoline derivatives and a process for preparing the same |
| 09/13/2011 | CA2440238C Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 09/07/2011 | EP2363394A1 8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its salts, solvates or hydrates and its use for the treatment of CNS disorders |
| 09/07/2011 | CN1662535B Spiroindolinepiperidine derivatives |
| 09/07/2011 | CN102174050A Method for separating and purifying coptis alkaloids by utilizing polyamide resin |
| 09/07/2011 | CN102174035A Aromatic dihydrazide type PLK1 (Polo-like Kinase 1) inhibitor and applications thereof |
| 09/07/2011 | CN101484456B Process for the preparation of asenapine and intermediate products used in said process. |
| 09/06/2011 | US8013170 Substituted pyrrolo[1,2-d][1,4]-diazonines and treatment of brain damage |
| 09/06/2011 | US8013158 Crystalline forms of topotecan hydrochloride and processes for making the same |
| 09/06/2011 | US8013151 Process for the preparation of galanthamine hydrobromide |
| 09/06/2011 | US8012996 Methods and composition for inhibition of angiogenesis |
| 09/06/2011 | US8012992 Aza-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity |
| 09/06/2011 | US8012975 Antitumoral analogs of ET-743 |
| 09/06/2011 | US8012961 Tricyclic antibiotics |
| 09/06/2011 | CA2670422C Spiroketone acetyl-coa carboxylase inhibitors |
| 09/01/2011 | WO2011106414A1 Inhibitors of beta-secretase |
| 09/01/2011 | WO2011105506A1 Cyclic amine compound and miticide |
| 09/01/2011 | WO2010132352A3 Spiro compounds and their use as therapeutic agents |
| 09/01/2011 | US20110213160 2,4,6-Phenyl-Substituted Derivatives |
| 09/01/2011 | US20110212986 Anti-flavivirus therapeutic |
| 09/01/2011 | US20110212970 Compounds that modulate intracellular calcium |
| 09/01/2011 | US20110212969 Substituted hydroxamic acids and uses thereof |
| 09/01/2011 | US20110212941 Imidazoisoindole Neuropeptide S Receptor Antagonists |
| 09/01/2011 | US20110212938 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |